… Here, we report the full set of safety and immunogenicity data from the phase 1 portion of an
… as well as the comparison of the safety and immunogenicity of both vaccine candidates and …

… high protection against COVID-19 infection in people … COVID-19 are limited. This study will
provide an integrated evaluation on the efficacy, safety, and immunogenicity of the COVID-19 …

… , the coronavirus disease 2019 (Covid-19) pandemic … a Covid-19 vaccine containing
nucleoside-modified messenger RNA encoding the severe acute respiratory syndrome coronavirus …

… studies reporting COVID-19 immunogenicity or safety, which were published since 2019
with no language restriction. Thus, we included all studies with various COVID-19 vaccine types…

… current COVID-19 vaccine candidates are safe, tolerated, and immunogenic, which provides
important … for further development, evaluation, and clinical application of COVID-19 vaccine. …

… programs against COVID-19. In this review, we have summarized and analyzed the efficacy,
immunogenicity and safety data from clinical reports on different COVID-19 vaccines. We …

… safety profiles of vaccines against SARS-CoV-2 in patients with cancer is unknown. We aimed
to assess the safety and immunogenicity … responses to COVID-19 vaccines in patients with …

… For further evaluation of the inactivated COVID-19 vaccine candidate BBIBP-CorV, we
assessed the safety and immunogenicity of BBIBP-CorV in participants aged 3–17 years. …

… Patients with secondary comorbidities have an increased risk of severe covid-19 [Citation29]…
to evaluate the safety, effectiveness, and immunogenicity of COVID-19 vaccines from Pfizer, …

… coronavirus disease (COVID)-19 pandemic caused by severe acute respiratory syndrome
coronavirus … study to assesses the safety, reactogenicity and immunogenicity of Ad26.COV2.S, …